Central muscle relaxants in rheumatology practice
Современная ревматология, 2021 The article describes the general principles of the treatment of musculoskeletal pain, discusses modern approaches to the treatment of osteoarthritis (OA) and nonspecific back pain (NBS).
E. Yu. Polishchuk +2 more
doaj +1 more source
Muscle weakness after muscle relaxants: An audit of clinical practice [PDF]
, 2004 Publisher's copy made available with the permission of the publisher © Australian Society of AnaesthetistsResidual muscle weakness after general anaesthesia, assessed using handgrip strength, was audited in a teaching hospital.
Alkhazrajy, W. +2 more
core +1 more source
Intraoperative Monitoring of Neuromuscular Blockade
Life, 2023 There is a global trend of new guidelines highly recommending quantitative neuromuscular monitoring in the operating room. In fact, it is almost certain that quantitatively monitoring the depth of intraoperative muscle paralysis may permit the rational ...
Cyrus Motamed
doaj +1 more source
Pharmacodynamic interactions between muscle relaxants and other medications in practice of anesthesia [PDF]
Farmacja Polska, 2023 Knowledge of drug interactions is an essential element of medical practice. Along with the increasing occurrence of multimorbidity and the associated multi-drug use, the number of possible combinations of preparations is constantly rising.
Paweł Radkowski, Rafał Marek Okoński
doaj +1 more source
Perioperative and anesthetic deaths: toxicological and medico legal aspects [PDF]
, 2019 Background: Anesthesia has become safer during decades, though there is still a preventable mortality; the complexity of medical and surgical interventions, increasingly older and sicker patients, has created a host of new hazards in anesthesiology.
Argo A. +5 more
core +1 more source
Muscle relaxants as alternative analgesics in the treatment of nonspecific back pain
Неврология, нейропсихиатрия, психосоматика, 2017 Only 50% of patients treated for back pain achieve effective relief. This is to some extent due to physicians' insufficient knowledge about the therapeutic strategies recommended in most expert guidelines.
G. R. Tabeeva
doaj +1 more source
The Evolution and Diversity of SALMFamide Neuropeptides [PDF]
, 2013 The SALMFamides are a family of neuropeptides that act as muscle relaxants in echinoderms. Two types of SALMFamides have been identified: L-type (e.g.
Achhala, S, Elphick, MR, Martynyuk, N
core +2 more sources
Tolperisone in the treatment of acute and chronic nonspecific back pain
Неврология, нейропсихиатрия, психосоматика, 2020 Nonspecific back pain (NBP) is one of the most common reasons to see a neurologist or therapist. Acute (<4 weeks' duration), subacute (4 to 12 weeks), and chronic (>12 weeks) NBPs are recognized.
V. A. Golovacheva +3 more
doaj +1 more source
Anesthetic management in a patient with Friedreichs Ataxia: a different approach
Medicine Science, 2017 Friedreich's Ataxia (FA) is a rare autosomal recessive disease. FA is clinically characterized by progressive ataxia, especially loss of reflex and power in the lower extremities, spasticity and loss of proprioceptive sensory.
Sedat Akbas, Erol Toy, Ahmet Selim Ozkan
doaj +1 more source
Neuromuscular Blockade with Rocuronium Bromide Increases the Tolerance of Acute Normovolemic Anemia in Anesthetized Pigs [PDF]
, 2012 Background: The patient's individual anemia tolerance is pivotal when blood transfusions become necessary, but are not feasible for some reason. To date, the effects of neuromuscular blockade (NMB) on anemia tolerance have not been investigated. Methods:
A. Pape +46 more
core +1 more source